Payment overview · 2025
General Payments
$29.26
1 reported records · 1 companies
Healthcare provider profile · identity verified
Javier Quant-Gonzalez, MD
Allopathic & Osteopathic Physicians|Internal Medicine · LINTHICUM HEIGHTS, MD · NPI 1134159163
Verified facts
What the public records show
CMS Open Payments records show Javier Quant-Gonzalez, MD received $29.26 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $29.26 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $29.26 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $29.26 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 698 | 113 |
| Levothyroxine Sodium | Levothyroxine Sodium | 595 | 83 |
| Furosemide | Furosemide | 487 | 88 |
| Eliquis | Apixaban | 459 | 62 |
| Amlodipine Besylate | Amlodipine Besylate | 456 | 75 |
| Potassium Chloride | Potassium Chloride | 424 | 71 |
| Gabapentin | Gabapentin | 420 | 60 |
| Pantoprazole Sodium | Pantoprazole Sodium | 302 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 279 | 49 |
| Tamsulosin Hcl | Tamsulosin Hcl | 273 | 35 |
| Famotidine | Famotidine | 264 | 54 |
| Metoprolol Succinate | Metoprolol Succinate | 253 | 44 |
| Lisinopril | Lisinopril | 240 | 32 |
| Losartan Potassium | Losartan Potassium | 216 | 33 |
| Mirtazapine | Mirtazapine | 205 | 38 |
| Sertraline Hcl | Sertraline Hcl | 204 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 199 | 28 |
| Omeprazole | Omeprazole | 199 | 34 |
| Metformin Hcl | Metformin Hcl | 180 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 179 | 23 |
| Tramadol Hcl | Tramadol Hcl | 174 | 38 |
| Clopidogrel | Clopidogrel Bisulfate | 165 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 158 | 17 |
| Myrbetriq | Mirabegron | 153 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 151 | 33 |
| Hydralazine Hcl | Hydralazine Hcl | 144 | 19 |
| Donepezil Hcl | Donepezil Hcl | 136 | 21 |
| Trazodone Hcl | Trazodone Hcl | 133 | 36 |
| Levetiracetam | Levetiracetam | 130 | 14 |
| Latanoprost | Latanoprost | 121 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 109 | 69 |
| Fluticasone Propionate | Fluticasone Propionate | 98 | 29 |
| Carvedilol | Carvedilol | 97 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 96 | 18 |
| Finasteride | Finasteride | 94 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 93 | 38 |
| Allopurinol | Allopurinol | 91 | 15 |
| Methenamine Hippurate | Methenamine Hippurate | 84 | 11 |
| Xarelto | Rivaroxaban | 83 | 19 |
| Buspirone Hcl | Buspirone Hcl | 79 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 76 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 76 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 72 | suppressed |
| Baclofen | Baclofen | 71 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 70 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 69 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 69 | 15 |
| Lorazepam | Lorazepam | 67 | 15 |
| Divalproex Sodium | Divalproex Sodium | 63 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 62 | suppressed |
| Memantine Hcl | Memantine Hcl | 61 | suppressed |
| Simvastatin | Simvastatin | 61 | suppressed |
| Spironolactone | Spironolactone | 56 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 55 | 33 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 54 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 53 | suppressed |
| Bupropion Xl | Bupropion Hcl | 53 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 53 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 53 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 52 | suppressed |
| Clonazepam | Clonazepam | 52 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 51 | 16 |
| Warfarin Sodium | Warfarin Sodium | 51 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 50 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 50 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 50 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 49 | 25 |
| Atenolol | Atenolol | 48 | suppressed |
| Bumetanide | Bumetanide | 48 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 47 | 11 |
| Levofloxacin | Levofloxacin | 46 | 20 |
| Oxybutynin Chloride | Oxybutynin Chloride | 46 | suppressed |
| Prednisone | Prednisone | 46 | 19 |
| Alprazolam | Alprazolam | 45 | suppressed |
| Folic Acid | Folic Acid | 45 | suppressed |
| Scopolamine | Scopolamine | 45 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 44 | suppressed |
| Digoxin | Digoxin | 44 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 44 | suppressed |
| Novolog Flexpen | Insulin Aspart | 43 | suppressed |
| Methotrexate | Methotrexate Sodium | 41 | suppressed |
| Gemtesa | Vibegron | 40 | suppressed |
| Lamotrigine | Lamotrigine | 40 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 39 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 39 | suppressed |
| Mupirocin | Mupirocin | 39 | 27 |
| Nystatin | Nystatin | 39 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 38 | 23 |
| Risperidone | Risperidone | 37 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 36 | suppressed |
| Levemir Flexpen | Insulin Detemir | 36 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 35 | suppressed |
| Lidocaine | Lidocaine | 34 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 32 | suppressed |
| Loperamide | Loperamide Hcl | 32 | 16 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 32 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | 11 |
| Rytary | Carbidopa/Levodopa | 30 | suppressed |
| Lactulose | Lactulose | 29 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 29 | suppressed |
| Sucralfate | Sucralfate | 29 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Meloxicam | Meloxicam | 28 | suppressed |
| Lacosamide | Lacosamide | 27 | suppressed |
| Methocarbamol | Methocarbamol | 27 | suppressed |
| Timolol Maleate | Timolol Maleate | 27 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 26 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 26 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 26 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 26 | suppressed |
| Entresto | Sacubitril/Valsartan | 25 | suppressed |
| Methimazole | Methimazole | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | suppressed |
| Erythromycin | Erythromycin Base | 24 | suppressed |
| Oxycontin | Oxycodone Hcl | 24 | suppressed |
| Restasis | Cyclosporine | 24 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 13 |
| Valsartan | Valsartan | 24 | suppressed |
| Budesonide | Budesonide | 23 | suppressed |
| Tradjenta | Linagliptin | 23 | suppressed |
| Cephalexin | Cephalexin | 22 | 15 |
| Olanzapine | Olanzapine | 22 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Pregabalin | Pregabalin | 21 | suppressed |
| Vascepa | Icosapent Ethyl | 21 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | suppressed |
| Primidone | Primidone | 20 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 20 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 19 |
| Ranolazine Er | Ranolazine | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 14 |
| Celecoxib | Celecoxib | 18 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 17 | 17 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 16 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Jardiance | Empagliflozin | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Ezetimibe | Ezetimibe | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | 15 |
| Rasagiline Mesylate | Rasagiline Mesylate | 15 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 13 | suppressed |
| Nadolol | Nadolol | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Azithromycin | Azithromycin | 12 | suppressed |
| Ethosuximide | Ethosuximide | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Mesalamine | Mesalamine | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $29.26 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error